| Heart disease and stroke statistics—2013 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ... circulation 127 (1), e6-e245, 2013 | 60416* | 2013 |
| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 29087* | 2016 |
| Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ... New England journal of medicine 361 (12), 1139-1151, 2009 | 14832 | 2009 |
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. S Yusuf, P Sleight, J Pogue, J Bosch, R Davies, G Dagenais The New England journal of medicine 342 (3), 145-153, 2000 | 8643 | 2000 |
| Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators New England Journal of Medicine 345 (7), 494-502, 2001 | 8226 | 2001 |
| Telmisartan, ramipril, or both in patients at high risk for vascular events Ontarget Investigators New England Journal of Medicine 358 (15), 1547-1559, 2008 | 5071 | 2008 |
| Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events … S Connolly, J Pogue, R Hart, M Pfeffer, S Hohnloser, S Chrolavicius, ... Lancet (London, England) 367 (9526), 1903-1912, 2006 | 3403* | 2006 |
| Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial POISE Study Group The Lancet 371 (9627), 1839-1847, 2008 | 2673 | 2008 |
| Homocysteine lowering with folic acid and B vitamins in vascular disease Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators New England Journal of Medicine 354 (15), 1567-1577, 2006 | 2368 | 2006 |
| Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients MD Flather, S Yusuf, L Køber, M Pfeffer, A Hall, G Murray, ... The Lancet 355 (9215), 1575-1581, 2000 | 2366 | 2000 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2294 | 2006 |
| Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial JFE Mann, RE Schmieder, M McQueen, L Dyal, H Schumacher, J Pogue, ... The Lancet 372 (9638), 547-553, 2008 | 2116 | 2008 |
| Basal insulin and cardiovascular and other outcomes in dysglycemia ORIGIN Trial Investigators New England Journal of Medicine 367 (4), 319-328, 2012 | 2082 | 2012 |
| Vitamin E supplementation and cardiovascular events in high-risk patients. S Yusuf, G Dagenais, J Pogue, J Bosch, P Sleight The New England journal of medicine 342 (3), 154-160, 2000 | 2036 | 2000 |
| Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial JFE Mann, HC Gerstein, J Pogue, J Bosch, S Yusuf, Hope Investigators Annals of internal medicine 134 (8), 629-636, 2001 | 1904 | 2001 |
| Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies L De Koning, AT Merchant, J Pogue, SS Anand European heart journal 28 (7), 850-856, 2007 | 1662 | 2007 |
| Comparison of fondaparinux and enoxaparin in acute coronary syndromes Fifth Organization to Assess Strategies in Acute Ischemic Syndromes ... New England Journal of Medicine 354 (14), 1464-1476, 2006 | 1512 | 2006 |
| Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. E Lonn, J Bosch, S Yusuf, P Sheridan, J Pogue, JM Arnold, C Ross, ... Jama 293 (11), 1338-1347, 2005 | 1491 | 2005 |
| Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot … RS McKelvie, S Yusuf, D Pericak, A Avezum, RJ Burns, J Probstfield, ... Circulation 100 (10), 1056-1064, 1999 | 1292 | 1999 |
| Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised … Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ... The Lancet 372 (9644), 1174-1183, 2008 | 1254 | 2008 |
Hertzel GersteinMcMaster UniversityEmail verificata su mcmaster.ca